Biochar-activated peroxydisulfate as an effective process to eliminate pharmaceutical and metabolite in hydrolyzed urine.

Eliminating pharmaceutical active compounds from source-separated urine is essential for nutrient recovery and reducing the contaminant load to wastewater treatment plants. However, limited oxidation treatment processes have shown satisfactory performance due to strong scavenging effect of urine components. This study proposed a heterogeneous catalytic system by combining biochar with peroxydisulfate (PDS), which effectively removed sulfamethoxazole (SMX) and its major human metabolite, N4-acetyl-sulfamethoxazole (NSMX) in urine. The performance of biochar/PDS was investigated in both a complete-mixing reactor and a biochar-packed column. Interestingly, urine components slightly inhibited the degradation of sulfonamides in biochar suspension but significantly improved their removal in biochar-packed column. Further investigation elucidated the PDS activation process and the effects of the main urine components, which explained the different results in biochar suspension and biochar-packed column. The biochar/PDS system mainly produced ·OH radical, singlet oxygen and surface-bound radicals (SBR), which transformed SMX to products of no apprarent antimicrobial properities. A cost-effective two-stage process was designed utilizing SBR as the major reactive species. This study may help to improve the understanding of the catalytic role of biochar and provide cost-effective treatment options for urine.